Immune Design ASH Data Release Play
Immune Design will report Phase 2 long-term follow up combo data due at ASH December 2, 2018 at 6:00PM for G100 for follicular non-Hodgkin Lymphoma. The company has a slide presentation here.
IMDZ Stock
That’s a powerful move off the bottom ahead of the ASH event this Sunday evening on December 2, 2018.
Disclosure: I am long IMDZ stock.
Immune Design News
Peptide Cancer Vaccine Market Pegged for Robust Expansion by 2025 - Press Release - Digital Journal
February 17, 2019
Peptide Cancer Vaccine Market Pegged for Robust Expansion by 2025 - Press Release Digital JournalThis press release was orginally distributed by SBWire. Albany, NY -- (SBWIRE) -- 02/17/2019 -- Vaccines are biological products which stimulate the immune ... ...February 17, 2019
Zevenbergen Capital Investments Has Cut Paylocity Holding (PCTY) Holding by $4.95 Million; Stock Value Declined; Portolan Capital Management Decreased Its Holding in Conns (CONN) by $320,950 as Shares Declined The FinExaminerZevenbergen Capital Investments Llc decreased its stake in Paylo ...February 17, 2019
Global Vaccine Delivery System Market 2019: Invectys, Peptech, Antigen Express, Apitope Technology, Circassia, Medinet Honest VersionGlobal Vaccine Delivery System Market has been blooming since last decade and simultaneously bolstering economic stability, stimulating progress in its peer ...Shares Continuing to Trade Below Moving Averages: Immune Design Corp. (NASDAQ:IMDZ) - Zeeland Press
February 17, 2019
Shares Continuing to Trade Below Moving Averages: Immune Design Corp. (NASDAQ:IMDZ) Zeeland PressImmune Design Corp. (NASDAQ:IMDZ) shares have experienced a recent steady downtrend, causing some concern for shareholders. Coming up with a viable ... ...February 17, 2019
Esprinet SpA (BIT:PRT), Immune Design Corp. (NasdaqGM:IMDZ) EBITDA Yield & Shareholder Return Update Kentwood PostThe EBITDA Yield is a great way to determine a company's profitability. This number is calculated by dividing a company's earnings before. ...February 16, 2019
Royal Gold (RGLD) Market Valuation Rose While Asa Gold & Precious Metals LTD Trimmed Stake by $1.93 Million; As Immune Design (IMDZ) Market Value Declined, Portolan Capital Management Has Boosted by $843,633 Its Stake The FinHeadLinesAsa Gold & Precious Metals Ltd decreased its st ...Immune Design Corp (IMDZ) Expected to Post Earnings of -$0.29 Per Share - Fairfield Current
February 16, 2019
Immune Design Corp (IMDZ) Expected to Post Earnings of -$0.29 Per Share Fairfield CurrentWall Street brokerages predict that Immune Design Corp (NASDAQ:IMDZ) will post ($0.29) earnings per share for the current fiscal quarter, Zacks reports. ...February 16, 2019
Trading Circle: MA Rating is Strong Sell on Shares of Immune Design Corp. (NASDAQ:IMDZ) Bay City ObserverInvestors are usually trying to take advantage of every possible market scenario. Tracking the market from many different angles can help the investor put. ...February 16, 2019
Replimune Group Inc (REPL) Expected to Earn Q1 2020 Earnings of ($0.34) Per Share Fairfield CurrentReplimune Group Inc (NASDAQ:REPL) – Equities research analysts at Svb Leerink issued their Q1 2020 earnings per share (EPS) estimates for Replimune ... ...February 16, 2019
Comparison of Alpine Immune Sciences Inc. (ALPN) and Inovio Pharmaceuticals Inc. (NASDAQ:INO) Standard RecorderThis is a contrast between Alpine Immune Sciences Inc. (NASDAQ:ALPN) and Inovio Pharmaceuticals Inc. (NASDAQ:INO) based on their institutional ownership ... ...